Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-04-21
1990-01-30
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548122, C07D29104, A61K 3141
Patent
active
048974056
ABSTRACT:
This invention relates to novel [(substituted naphthalenyl)alkyl]-3H-1,2,3,5-oxathiadiazole 2-oxides, to the processes for their preparation, to methods for using the compounds, and to pharmaceutical compositions thereof. The compounds have pharmaceutical properties which render them beneficial for the treatment of diabetes mellitus and associated conditions.
REFERENCES:
patent: 4148801 (1979-04-01), Santilli
Dondoni, J. Org. Chem. 42 3372 (1977).
Eloy, Bull. Soc. Chim. Belg. 74, 129 (1965).
A. Dondoni et al., J. Org. Chem., 42 (21), 3372-3377 (1977).
A. Y. Chang et al., Diabetes, 32, 830-838 (1983).
Alessi Thomas R.
Dolak Terence M.
Ellingboe John W.
Lombardo Louis J.
American Home Products Corporation
Gerstl Robert
Patton Walter
LandOfFree
Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides usefu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides usefu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides usefu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923669